T4684	CHEBI:50114 20 28	estrogen
T4685	CHEBI:66075 29 36	insulin
T4686	CHEBI:50114 144 152	Estrogen
T4687	CHEBI:43176 274 280	highly
T4688	CHEBI:16541 291 298	protein
T4689	CHEBI:37527 385 387	as
T4690	CHEBI:27007 492 495	the
T4691	CHEBI:19048 499 500	-
T4692	CHEBI:46629 594 599	study
T4693	CHEBI:24870 601 605	this
T4694	CHEBI:49168 683 692	deficient
T4695	CHEBI:9185 694 701	SirT1ko
T4696	CHEBI:25435 792 800	mutation
T4697	CHEBI:9688 878 887	histology
T4698	CHEBI:17996 896 897	,
T4699	CHEBI:22339 1032 1035	and
T4700	CHEBI:15378 1065 1074	exogenous
T4701	CHEBI:25754 1084 1087	was
T4702	CHEBI:22339 1205 1208	and
T4703	CHEBI:9185 1216 1223	SirT1ko
T4704	CHEBI:43448 1304 1306	ko
T4705	CHEBI:83466 1312 1321	displayed
T4706	CHEBI:6353 1439 1453	lobuloalveolar
T4707	CHEBI:61215 1489 1499	sufficient
T4708	CHEBI:33893 1503 1509	rescue
T4709	CHEBI:27007 1560 1563	the
T4710	CHEBI:22695 1574 1579	basal
T4711	CHEBI:18133 1655 1658	but
T4712	CHEBI:77571 1825 1834	treatment
T4713	CHEBI:27007 1844 1847	the
T4714	CHEBI:83220 1932 1939	affects
T4715	CHEBI:3478 1944 1952	cellular
T4716	CHEBI:27007 2022 2025	the
T4717	CHEBI:19048 2029 2030	-
T4718	CHEBI:27007 2146 2149	the
T4719	CHEBI:33290 2161 2163	of
T4720	CHEBI:35287 2232 2241	including
T4721	CHEBI:32198 2346 2350	that
T4722	CHEBI:81994 2355 2364	enzymatic
T4723	CHEBI:22868 2497 2504	belongs
T4724	20 2508 2509	a
T4725	CHEBI:37963 2606 2613	closely
T4726	900 2622 2624	to
T4727	CHEBI:30879 8491 8498	alcohol
T4728	CHEBI:37527 8624 8626	as
T4729	CHEBI:6793 8693 8695	ml
T4730	CHEBI:51687 8842 8847	cells
T4731	CHEBI:22663 9024 9026	at
T4732	CHEBI:27007 9219 9222	the
T4733	CHEBI:19048 9348 9349	-
T4734	CHEBI:4999 9539 9545	female
T4735	CHEBI:46950 9672 9678	spread
T4736	CHEBI:37607 10050 10054	were
T4737	CHEBI:87100 10222 10229	tissues
T4738	CHEBI:51274 10351 10360	thickness
T4739	20 10586 10587	a
T4740	CHEBI:24868 10929 10931	on
T4741	CHEBI:37527 11105 11107	as
T4742	CHEBI:75927 11176 11181	SirT1
T4743	CHEBI:59132 11460 11464	anti
T4744	CHEBI:7507 11698 11706	neomycin
T4745	CHEBI:75927 12122 12127	SirT1
T4746	CHEBI:33290 12316 12318	).
T4747	CHEBI:32198 12539 12543	that
T4748	CHEBI:472552 12789 12790	4
T4749	8405 12953 12954	/
T4750	CHEBI:33290 13152 13154	of
T4751	CHEBI:19048 13745 13746	-
T4752	CHEBI:19048 13982 13983	-
T4753	CHEBI:33284 36795 36804	nutrients
T4754	CHEBI:7983 36985 36996	prepubertal
T4755	CHEBI:27007 37179 37182	the
T4756	CHEBI:52043 37372 37381	therefore
T4757	CHEBI:75927 37595 37600	SirT1
T4758	CHEBI:22339 37738 37741	and
T4759	CHEBI:33290 37994 37996	of
T4760	CHEBI:27007 38356 38359	the
T4761	CHEBI:37902 38550 38554	well
T4762	CHEBI:35222 38728 38736	receptor
T4763	CHEBI:33290 39458 39460	of
T4764	CHEBI:37958 39756 39757	.
T4765	CHEBI:60004 42012 42016	milk
T4766	CHEBI:60004 42127 42131	milk
T4767	CHEBI:25405 42296 42309	morphogenesis
T4768	CHEBI:33290 42336 42338	of
T4769	CHEBI:49705 42389 42394	(+/+)
T4770	CHEBI:43448 42628 42630	ko
T4771	CHEBI:9654 42728 42740	transitional
T4772	CHEBI:37958 42853 42854	.
T4773	CHEBI:33290 42881 42883	of
T4774	CHEBI:37607 43090 43097	control
T4775	CHEBI:33290 43140 43142	of
T4776	CHEBI:60246 43301 43311	elongation
T4777	CHEBI:33290 43357 43359	of
T4778	CHEBI:33290 43539 43541	of
T4779	CHEBI:22339 43823 43826	and
T4780	CHEBI:472552 43893 43909	bromodeoxyurdine
